Date of Approval: September 19, 2005 FREEDOM OF INFORMATION (FOI) SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG

First Page		Document Content
Chemistry Food law Antibiotics Ionophores Monensin Tylosin Pharmacia Title 21 of the Code of Federal Regulations Upjohn Pfizer Pharmacology Medicine		Date of Approval: September 19, 2005 FREEDOM OF INFORMATION (FOI) SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 85,28 KB Share Document on Facebook

	Heterodox Economics Newsletter HUMAN RESOURCE ECONOMICS AND PUBLIC POLICY: ESSAYS IN HONOR OF VERNON M. BRIGGS, JR. edited by Charles J. Whalen. Kalamazoo, Michigan: W.E. Upjohn Institute for Employment Research; ix, 305 DocID: 1uHuC - View Document
	California Association of Toxicologists New Drugs Committee Report Reboxetine (Vestra®) General Reboxetine is a very new anti-depressant manufactured by Pharmacia & Upjohn and is currently distributed in Europe under th DocID: 1ue9l - View Document
	California Association of Toxicologists New Drugs Committee Report Reboxetine (Vestra®) General Reboxetine is a very new anti-depressant manufactured by Pharmacia & Upjohn and is currently distributed in Europe under th DocID: 1u8IE - View Document
	OctoberIs American Manufacturing in Decline? Susan Houseman U.S. manufacturing has been in the spotlight in this presidential campaign. The candidates, most notably Donald Trump and Bernie Sanders, have argued tha DocID: 1tsJ3 - View Document
	PDF Document DocID: 1t1UF - View Document